UNIS Archives - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Continued Options Tracking & More

Options Recap

To start things off today we’ll be going over the continued success of our running options ideas for the week. During market conditions like the ones we’ve been seeing, oftentimes big gains from stocks can be fewer and farther between, so it’s nice to be able to fall back on options trading. Quarterly periods where earnings reports are dropping with the highest frequency really provides a lot of great chances for quick strike profits.

Ford Motor Co. (F) – Ford has been an excellent example of a massive gainer in a short span. We’ve been tracking F Weekly $14.50 and $15 Calls since Tuesday, at which time we observed lows of .18 and .02 respectively. After the $14.50’s made huge gains possible for us that day, the $15’s joined in yesterday and both sets went haywire.

The $14.50’s ran from a daily low of .35 to a high of .78; an intraday romp of 123%

The $15’s traded in a massive range from .05-.32, giving daytraders a shot at gains of up to 540% on the session, and giving us yet another multi-bag call in what has been a landmark week for our options-trading ideas!
___

Pfizer, Inc. PFE – We also offered suggestions for Pfizer in the same Tuesday report, the PFE Weekly $34.50 and $35 Calls. We saw lows of .26 and .10 respectively for those contracts. Yesterday, new highs were set in both cases, with the $34.50’s making a total move of 476% to 1.50, and the $35’s ramping up to the tune of 970% as they surged as high as 1.07.
___
YESTERDAY’S NEW IDEAS

Following a recap of the two preceding plays in yesterday’s morning report, we presented a couple of fresh ideas and both of those ended up yielding significant opportunities as well:

Twitter, Inc. TWTR – We went bearish on TWTR and submitted our interest in the Weekly $34-32 Puts, and the chances to gain were plentiful:$34 Puts – Daily Range: 1.32-3.60 – Max Gain: 173%
$33.50 Puts – Daily Range: 1.00-2.35 – Max Gain: 135%
$33 Puts – Daily Range: .76-2.00 – Max Gain: 163%
$32.50 Puts – Daily Range: .55-1.48 – Max Gain: 169%
$32 Puts – Daily Range: .38-1.12 – Max Gain: 123%
___

Micron Technologies, Inc. MU – For MU we drew attention to Weekly $19-20.50 Calls and were met with some nice opportunities there also. $19.50 ran from .75-1.10 (+47%) and the $20 Calls traded in a range from .40-.75 (+88%).

Mobile Broadcasting Holding, Inc. MBHC

MBHC has released a fresh PR this morning that we’ll suggest all our readers take a look at, as it pertains to the company’s ‘Whirld’ app which, if everything remains in step with the timeline previously given by MBHC, is slated for official launch in mid-August.

Here’s a look at the current chart for MBHC on the snapshot below. The stock has managed to hold support off of the 50DMA amid recent consolidation, and we’ll be on the lookout for it to get its next leg up soon, especially with the app launch just a couple of short weeks away:

PISCATAWAY TOWNS, NJ / ACCESSWIRE / July 30, 2015 / Mobile Broadcasting Corporation, (OTC PINK: MBHC) Mobile Broadcasting Corporation (MBC) announced today the findings from their current Apple iTunes BETA test and their plans to engage and work directly with EDM VLOGGERS and DJ MIX BROADCASTERS that have a combined MONTHLY fan base of 200 MM + consumers for the upcoming global launch of WHIRLD WITHIN iTunes and Google Play Storefronts. >>PR FULL

Extended Watchlist:
SGYP, OWW, UNIS, MWW, GEVO, AKS, LPSN

Blue Horseshoe Stocks: PZOO Follow-Up

Pazoo, Inc. PZOO

We’re touching base with PZOO once again this morning. We brought it into the fold last Monday while the stock was trading at a low of .0225 and not only has it brought us a couple of quality chances for swing trades, it has held its ground extremely well over the past week, and has begun to spike once again.

Over the few sessions prior, PZOO had toyed with resistance at the 200DMA (.0339), and yesterday it managed to close above that mark for the first time. As usual, moving forward, we want to see that previous resistance level hold as future support. We’ll want to see the stock maintain above a minimum of .0261. From where it stands now, we’re looking at the next key resistance points coming up at .05 and .065.

If you didn’t catch our initial report on PZOO last Monday, we suggest taking a look at that to learn about the company’s online health and wellness portal, as well as the involvement it has in the cannabis sector. >> View PZOO Report

There has been two new statements issued by the company over the past couple of days that we’ll pass along here:

Yesterday PZOO announced that it was a main sponsor at the Just Jersey Jazz and Food Truck Festival on Sunday October 19th at Horse Shoe Lake in Succasunna, New Jersey >>> Click to View PR

This morning we’ve learned that PZOO has increased its stake in the medical marijuana testing labs by 10%, effectively creating a controlling interest for itself in the company currently running the project >>> Click to View PR

Also, take a look at this video chart update we put together on PZOO:

For More Info Check Out PAZOO.COM

Extended Watchlist:
FCAU, CARA, UNIS, MEA, AKS, VSR

Blue Horseshoe Stocks: Potential Bottom Play & More

Yesterday’s Top Picks

Wednesday was a pretty good day for a couple plays off of our watchlist; top billing goes to an ETF rather than a stock.

We tagged JNUG (gold miner’s bull index) and were pleased at the scope of the run we witnessed. Over an impressive daily range from 8.43 to 12.35, it offered us the chance at gains in excess of 46%

Meanwhile, UNIS registered a solid 25% intraday move as it spiked from a morning low of 2.78 on up to 3.49. Both plays blew their 3-month average trading volume out of the water for the day.

First Liberty Power Corp. FLPC

We also want to flag FLPC today for a number of different reasons. This subpenny stock is coming off of a recent bottom, and has recorded higher lows and higher highs for the last 4 consecutive sessions. Yesterday it broke above its 50DMA (.002), and we’re going to be looking for support to hold at or above that mark in order for us to remain interested.

A quick view of the chart reveals some of the potential of FLPC:

Extended Watchlist:
HKUP, RT, PBR, JBLU, FCEL, BLDP, PLUG,

Blue Horseshoe Stocks: GTAT Recap & More

GT Advanced Technologies, Inc. GTAT

The unmatched winner of yesterday’s report definitely has to be GTAT. This gem came off of our extended watchlist, and had a breakout session. The impressive run began at a morning low of .88, and the stock continually pushed the envelope, reaching an afternoon high of 2.00.

The move came to an impressive intraday gain of 127% on 17X the three-month average volume. Cheers to all the folks who were able to carve a slice off of the pie!

The PPS did taper into the close, pulling back to 1.21, but is gapping up this morning, with GTAT thus far having traded as high as the 1.60’s in the premarket.

Recapping Yesterday’s Options Idea

Yesterday morning we raised a flag on the November $16 PBR Calls, and our bait wasn’t in the water long before we got a bite. PBR would briefly crack the $17-mark by early afternoon setting the stage for a solid chance.

Our contracts of interest traded in a range from 2.00 to as high as 2.70, making for a 35% intraday swing. With plenty of time before expiration, we could still see further action on the Nov. $16’s, so they’ll stay on our radar for the time being.

Extended Watchlist:
JNUG, SCOK, OXGN, UNIS,

CNAT, GOGO, UNIS, CAMT & Extended Watchlist

Conatus Pharmaceuticals, Inc. CNAT

We caught CNAT on our scanner this morning, and is definitely a stock we’d like to keep an eye on today, following an FDA-related announcement regarding a drug that the company has under development receiving “Orphan Drug” status. FDA plays have provided us with countless opportunities in the past, especially when the news is untraded upon, so we’ll be interested to see how well CNAT fares today as a result.

SAN DIEGO, Dec. 2, 2013 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (CNAT), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Conatus’ drug candidate emricasan for the treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end-stage liver disease. The FDA’s Orphan Drug Designation program is intended to encourage the development of drugs and biologics that may provide benefit to patients suffering from rare diseases or conditions.

Conatus is developing emricasan, a first-in-class, orally active caspase protease inhibitor designed to reduce the activity of enzymes that mediate inflammation and cell death (or apoptosis), for the treatment of patients with chronic liver disease and significant unmet medical need.

GOGO, Inc. GOGO

We have been hot on the trail of GOGO since our first mention on Monday Sept. 16th when it was trading as low as 14.79. We witnessed the stock’s 52-wk high a few weeks later on Nov. 14th (31.55), and then it consolidated to find support at 24.24.

Yesterday, GOGO re-established its 52-wk high at 31.65, and appears to want to gap up and continue its run today. This morning, the company has news out concerning the green light is has received to install its wifi satellite technology on Boeing 747 aircraft. and we’ve seen pre-market trades going off as high as 32.75. From our original alert price, that marks registers as a 121% gain. Heading into today’s session, we’d like to see the previous 52-wk high of 31.55 hold as support on any future pullbacks.

ITASCA, Ill., Dec. 2, 2013 /PRNewswire via COMTEX/ — Gogo (NASDAQ: GOGO), the world leader of in-flight connectivity and a pioneer in wireless in-flight digital entertainment solutions, passed a key milestone in launching its international connectivity service by receiving an STC to install its Ku-satellite technology on Boeing 747-400 aircraft.

Gogo will begin testing the new service immediately and plans to offer the service for customer usage by the first quarter of 2014. The technology will give travelers and crew access to the Internet. The service will also offer passengers Gogo Vision, Gogo’s wireless in-flight entertainment service.

Unilife Corp. UNIS

UNI hits our radar screens as another play with fresh news and a chart that is gapping up premarket. UNIS has a potentially lucrative arrangement in the works with European Pharma giant, Novartis.

YORK, Pa., Dec. 2, 2013 /PRNewswire/ — Unilife Corporation (“Unilife” or “Company”) (NASDAQ: UNIS, ASX: UNS) today announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis’ targeted early-stage pipeline drugs.

Under this agreement, Unilife will supply Novartis with a customized delivery device, consisting of syringe, needle, tubing, controller and pump, to enable administration of a novel investigational Novartis drug into a targeted organ in clinical trials. Unilife has granted Novartis an option for exclusivity under this agreement.

Camtek, Ltd. CAMT

Yesterday wasn’t the first time we’ve mentioned CAMT on our extended watchlist only to see the stock turn in an impressive performance; last Monday, we tagged CAMT as a possible runner, and subsequently witnessed a pop from 4.11-5.29 (+29%). In a repeat of that scenario, yesterday we saw the stock trade from a low of 4.20 on up to 5.75, for a possible gain of 37%

Cheers to anyone who was able to take advantage of those very timely alerts!

Extended Watchlist:
IACH, OMED, ETRM, FRO, DGLY, NAVB